Lung disease associated with alpha1-antitrypsin deficiency.
about
Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experienceExpanding the clinical indications for α(1)-antitrypsin therapyDeficiency of α-1-antitrypsin influences systemic iron homeostasisSplicing variants of SERPINA1 gene in ovine milk: characterization of cDNA and identification of polymorphismsAFM Imaging Reveals Topographic Diversity of Wild Type and Z Variant Polymers of Human α1-Proteinase InhibitorAlpha-1 Antitrypsin and Lung Cell Apoptosis.Treg/IL-17 ratio and Treg differentiation in patients with COPD.NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?Identification of α1-Antitrypsin as a Potential Candidate for Internal Control for Human Synovial Fluid in Western Blot.Alcohol use predicts ER visits in individuals with alpha-1 antitrypsin deficiency (AATD) associated COPDModeling the influence of vitamin D deficiency on cigarette smoke-induced emphysema.Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.Chronic Obstructive Pulmonary Disease and its Non-Smoking Risk Factors in India.Neutrophil Fates in Bronchiectasis and Alpha-1 Antitrypsin Deficiency.Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.α-Linoleic acid enhances the capacity of α-1 antitrypsin to inhibit lipopolysaccharide-induced IL-1β in human blood neutrophilsDistribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.Impact of HIV Infection on Alpha-1 Antitrypsin in the Lung.Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease.High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.
P2860
Q26850621-F3C7DCF0-F9EC-4F36-AC16-EF8BEB842AEBQ27000764-D0433731-1865-44B7-AF3C-E0E3598C60E3Q28393697-2EAACD8A-4DC1-499A-80D0-9833272802E5Q28535592-6B5712A0-A653-4A13-9FE2-CDC81E5FA89DQ28550962-3C34AD72-07A3-4D71-8838-730179E575BBQ33783269-8AFE633F-67A6-4322-8E4E-F5600B0DDE2CQ34352247-561AA0FB-9D12-4EBE-9C39-BBC45E6CB197Q35977261-BEB454B3-D10F-467A-8E72-7BD2C1CB10A1Q36292289-8BF1D68B-6959-4413-AE77-575D832CDE4BQ36701417-D45FD46C-6E81-4522-BDF3-CBAC2BD11176Q36920859-B1B09419-4B23-4AAF-B1EB-12323ADA37D2Q37986292-97548930-9466-4385-B33A-CE2276D276DBQ38603104-358B4DBD-BC75-4742-A539-F629E76F6B1CQ38875787-2FB7CBC1-5227-40D5-AE3D-F1038200EC17Q38937862-50C71688-669A-4137-9700-A5626DFC66B6Q39565971-2B8B05FF-F3B5-43B7-9780-0D357FAC83E9Q40066585-E50641A1-A516-499E-A4CD-E8312969FE97Q47643314-40E6D409-792F-4CDC-A6F2-46EFACBD39E2Q47680491-A75D2EC7-CA80-42F9-B910-0B808FEDBC49Q47747847-5120C4D8-11EA-43AC-9830-68DC29817E69Q53075740-E4E0A044-F5E1-4015-B272-6FB8F4D49E0C
P2860
Lung disease associated with alpha1-antitrypsin deficiency.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Lung disease associated with alpha1-antitrypsin deficiency.
@en
Lung disease associated with alpha1-antitrypsin deficiency.
@nl
type
label
Lung disease associated with alpha1-antitrypsin deficiency.
@en
Lung disease associated with alpha1-antitrypsin deficiency.
@nl
prefLabel
Lung disease associated with alpha1-antitrypsin deficiency.
@en
Lung disease associated with alpha1-antitrypsin deficiency.
@nl
P2093
P2860
P1476
Lung disease associated with alpha1-antitrypsin deficiency.
@en
P2093
Irina Petrache
Rubin M Tuder
Sabina M Janciauskiene
P2860
P304
P356
10.1513/PATS.201002-020AW
P577
2010-11-01T00:00:00Z